sulfamethoxypyridazine has been researched along with Arteriosclerosis in 1 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MACCAFERRI, A | 1 |
| TROCCOLI, B | 1 |
1 other study available for sulfamethoxypyridazine and Arteriosclerosis
| Article | Year |
|---|---|
[ON THE ANTIPHLOGISTIC-ANTIPYRETIC ACTIVITY OF A NEW PHARMACOLOGIC COMBINATION IN GERIATRIC THERAPEUTIC PRACTICE].
Topics: Aminopyrine; Antipyretics; Antitussive Agents; Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Biome | 1964 |